Loading	O
of	O
DNA	O
-	O
binding	O
factors	O
to	O
an	O
erythroid	O
enhancer	S-ENHANCER
.	O


The	O
HS	B-ENHANCER
-	I-ENHANCER
40	I-ENHANCER
enhancer	E-ENHANCER
is	O
the	O
major	O
cis	O
-	O
acting	O
regulatory	O
element	O
responsible	O
for	O
the	O
developmental	O
stage	O
-	O
and	O
erythroid	O
lineage	O
-	O
specific	O
expression	O
of	O
the	O
human	O
alpha	O
-	O
like	O
globin	O
genes	O
,	O
the	O
embryonic	O
zeta	O
and	O
the	O
adult	O
alpha2	O
/	O
alpha	O
/	O
1	O
.	O


A	O
model	O
has	O
been	O
proposed	O
in	O
which	O
competitive	O
factor	O
binding	O
at	O
one	O
of	O
the	O
HS	B-ENHANCER
-	I-ENHANCER
40	E-ENHANCER
motifs	O
,	O
3	O
'	O
-	O
NA	O
,	O
modulates	O
the	O
capability	O
of	O
HS	B-ENHANCER
-	I-ENHANCER
40	E-ENHANCER
to	O
activate	O
the	O
embryonic	O
zeta	O
-	O
globin	O
promoter	O
.	O


Furthermore	O
,	O
this	O
modulation	O
was	O
thought	O
to	O
be	O
mediated	O
through	O
configurational	O
changes	O
of	O
the	O
HS	B-ENHANCER
-	I-ENHANCER
40	I-ENHANCER
enhanceosome	E-ENHANCER
during	O
development	O
.	O


In	O
this	O
study	O
,	O
we	O
have	O
further	O
investigated	O
the	O
molecular	O
basis	O
of	O
this	O
model	O
.	O


First	O
,	O
human	O
erythroid	O
K562	O
cells	O
stably	O
integrated	O
with	O
various	O
HS	B-ENHANCER
-	I-ENHANCER
40	E-ENHANCER
mutants	O
cis	O
linked	O
to	O
a	O
human	O
alpha	O
-	O
globin	O
promoter	O
-	O
growth	O
hormone	O
hybrid	O
gene	O
were	O
analyzed	O
by	O
genomic	O
footprinting	O
and	O
expression	O
analysis	O
.	O


By	O
the	O
assay	O
,	O
we	O
demonstrate	O
that	O
factors	O
bound	O
at	O
different	O
motifs	O
of	O
HS	B-ENHANCER
-	I-ENHANCER
40	E-ENHANCER
indeed	O
act	O
in	O
concert	O
to	O
build	O
a	O
fully	O
functional	O
enhanceosome	S-ENHANCER
.	O


Thus	O
,	O
modification	O
of	O
factor	O
binding	O
at	O
a	O
single	O
motif	O
could	O
drastically	O
change	O
the	O
configuration	O
and	O
function	O
of	O
the	O
HS	B-ENHANCER
-	I-ENHANCER
40	I-ENHANCER
enhanceosome	E-ENHANCER
.	O


Second	O
,	O
a	O
specific	O
1	O
-	O
bp	O
,	O
GC	O
-	O
-	O
>	O
TA	O
mutation	O
in	O
the	O
3	O
'	O
-	O
NA	O
motif	O
of	O
HS	B-ENHANCER
-	I-ENHANCER
40	E-ENHANCER
,	O
3	O
'	O
-	O
NA	O
(	O
II	O
)	O
,	O
has	O
been	O
shown	O
previously	O
to	O
cause	O
significant	O
derepression	O
of	O
the	O
embryonic	O
zeta	O
-	O
globin	O
promoter	O
activity	O
in	O
erythroid	O
cells	O
.	O


This	O
derepression	O
was	O
hypothesized	O
to	O
be	O
regulated	O
through	O
competitive	O
binding	O
of	O
different	O
nuclear	O
factors	O
,	O
in	O
particular	O
AP1	O
and	O
NF	O
-	O
E2	O
,	O
to	O
the	O
3	O
'	O
-	O
NA	O
motif	O
.	O


By	O
gel	O
mobility	O
shift	O
and	O
transient	O
cotransfection	O
assays	O
,	O
we	O
now	O
show	O
that	O
3	O
'	O
-	O
NA	O
(	O
II	O
)	O
mutation	O
completely	O
abolishes	O
the	O
binding	O
of	O
small	O
MafK	O
homodimer	O
.	O


Surprisingly	O
,	O
NF	O
-	O
E2	O
as	O
well	O
as	O
AP1	O
can	O
still	O
bind	O
to	O
the	O
3	O
'	O
-	O
NA	O
(	O
II	O
)	O
sequence	O
.	O


The	O
association	O
constants	O
of	O
both	O
NF	O
-	O
E2	O
and	O
AP1	O
are	O
similar	O
to	O
their	O
interactions	O
with	O
the	O
wild	O
-	O
type	O
3	O
'	O
-	O
NA	O
motif	O
.	O


However	O
,	O
the	O
3	O
'	O
-	O
NA	O
(	O
II	O
)	O
mutation	O
causes	O
an	O
approximately	O
twofold	O
reduction	O
of	O
the	O
binding	O
affinity	O
of	O
NF	O
-	O
E2	O
factor	O
to	O
the	O
3	O
'	O
-	O
NA	O
motif	O
.	O


This	O
reduction	O
of	O
affinity	O
could	O
be	O
accounted	O
for	O
by	O
a	O
twofold	O
-	O
higher	O
rate	O
of	O
dissociation	O
of	O
the	O
NF	O
-	O
E2	O
-	O
3	O
'	O
-	O
NA	O
(	O
II	O
)	O
complex	O
.	O


Finally	O
,	O
we	O
show	O
by	O
chromatin	O
immunoprecipitation	O
experiments	O
that	O
only	O
binding	O
of	O
NF	O
-	O
E2	O
,	O
not	O
AP1	O
,	O
could	O
be	O
detected	O
in	O
vivo	O
in	O
K562	O
cells	O
around	O
the	O
HS	B-ENHANCER
-	I-ENHANCER
40	I-ENHANCER
region	E-ENHANCER
.	O


These	O
data	O
exclude	O
a	O
role	O
for	O
AP1	O
in	O
the	O
developmental	O
regulation	O
of	O
the	O
human	O
alpha	O
-	O
globin	O
locus	O
via	O
the	O
3	O
'	O
-	O
NA	O
motif	O
of	O
HS	B-ENHANCER
-	I-ENHANCER
40	E-ENHANCER
in	O
embryonic	O
/	O
fetal	O
erythroid	O
cells	O
.	O


Furthermore	O
,	O
extrapolation	O
of	O
the	O
in	O
vitro	O
binding	O
studies	O
suggests	O
that	O
factors	O
other	O
than	O
NF	O
-	O
E2	O
,	O
such	O
as	O
the	O
small	O
Maf	O
homodimers	O
,	O
are	O
likely	O
involved	O
in	O
the	O
regulation	O
of	O
the	O
HS	B-ENHANCER
-	I-ENHANCER
40	E-ENHANCER
function	O
in	O
vivo	O
.	O
